|
Ahnen, D.J. (1998). Colon cancer prevention by NSAIDs: what is the mechanism of action? Eur J Surg Suppl 111-114.
Alberts, D.S., Hixson, L., Ahnen, D., Bogert, C., Einspahr, J., Paranka, N., Brendel, K., Gross, P.H., Pamukcu, R., and Burt, R.W. (1995). Do NSAIDs exert their colon cancer chemoprevention activities through the inhibition of mucosal prostaglandin synthetase? J Cell Biochem Suppl 22, 18-23.
August, D.A., Landau, J., Caputo, D., Hong, J., Lee, M.J., and Yang, C.S. (1999). Ingestion of green tea rapidly decreases prostaglandin E2 levels in rectal mucosa in humans. Cancer Epidemiol Biomarkers Prev 8, 709-713.
Barch, D.H. and Fox, C.C. (1988). Selective inhibition of methylbenzylnitrosamine-induced formation of esophageal O6-methylguanine by dietary ellagic acid in rats. Cancer Res 48, 7088-7092.
Bauer, A.K., Dwyer-Nield, L.D., and Malkinson, A.M. (2000). High cyclooxygenase 1 (COX-1) and cyclooxygenase 2 (COX-2) contents in mouse lung tumors. Carcinogenesis 21, 543-550.
Chan, G., Boyle, J.O., Yang, E.K., Zhang, F., Sacks, P.G., Shah, J.P., Edelstein, D., Soslow, R.A., Koki, A.T., Woerner, B.M., Masferrer, J.L., and Dannenberg, A.J. (1999). Cyclooxygenase-2 expression is up-regulated in squamous cell carcinoma of the head and neck. Cancer Res 59, 991-994.
Chang, K.W., Lin, S.C., Koos, S., Pather, K., and Solt, D. (1996). p53 and Ha-ras mutations in chemically induced hamster buccal pouch carcinomas. Carcinogenesis 17, 595-600.
Chang, K.W., Sarraj, S., Lin, S.C., Tsai, P.I., and Solt, D. (2000). P53 expression, p53 and Ha-ras mutation and telomerase activation during nitrosamine-mediated hamster pouch carcinogenesis. Carcinogenesis 21, 1441-1451.
Chung, F.L. (1999). The prevention of lung cancer induced by a tobacco-specific carcinogen in rodents by green and black tea. Proc Soc Exp Biol Med 220, 244-248.
Coffey, R.J., Hawkey, C.J., Damstrup, L., Graves-Deal, R., Daniel, V.C., Dempsey, P.J., Chinery, R., Kirkland, S.C., DuBois, R.N., Jetton, T.L., and Morrow, J.D. (1997). Epidermal growth factor receptor activation induces nuclear targeting of cyclooxygenase-2, basolateral release of prostaglandins, and mitogenesis in polarizing colon cancer cells. Proc Natl Acad Sci U S A 94, 657-662.
Denkert, C., Kobel, M., Berger, S., Siegert, A., Leclere, A., Trefzer, U., and Hauptmann, S. (2001). Expression of cyclooxygenase 2 in human malignant melanoma. Cancer Res 61, 303-308.
Fischer, S.M., Lo, H.H., Gordon, G.B., Seibert, K., Kelloff, G., Lubet, R.A., and Conti, C.J. (1999). Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, and indomethacin against ultraviolet light-induced skin carcinogenesis. Mol Carcinog 25, 231-240.
Fosslien, E. (2000). Biochemistry of cyclooxygenase (COX)-2 inhibitors and molecular pathology of COX-2 in neoplasia. Crit Rev Clin Lab Sci 37, 431-502.
Fosslien, E. (2000). Molecular pathology of cyclooxygenase-2 in neoplasia. Ann Clin Lab Sci 30, 3-21.
Gately, S. (2000). The contributions of cyclooxygenase-2 to tumor angiogenesis. Cancer Metastasis Rev 19, 19-27.
Goldberg, Y., Nassif, I.I., Pittas, A., Tsai, L.L., Dynlacht, B.D., Rigas, B., and Shiff, S.J. (1996). The anti-proliferative effect of sulindac and sulindac sulfide on HT-29 colon cancer cells: alterations in tumor suppressor and cell cycle-regulatory proteins. Oncogene 12, 893-901.
Goluboff, E.T., Shabsigh, A., Saidi, J.A., Weinstein, I.B., Mitra, N., Heitjan, D., Piazza, G.A., Pamukcu, R., Buttyan, R., and Olsson, C.A. (1999). Exisulind (sulindac sulfone) suppresses growth of human prostate cancer in a nude mouse xenograft model by increasing apoptosis. Urology 53, 440-445.
Goodsell, D.S. (2000). The molecular perspective: cyclooxygenase-2. Stem Cells 18, 227-229.
Hawkey, C.J. (1999). COX-2 inhibitors. Lancet 353, 307-314.
Herschman, H.R. (1996). Prostaglandin synthase 2. Biochim Biophys Acta 1299, 125-140.
Hsu, A.L., Ching, T.T., Wang, D.S., Song, X., Rangnekar, V.M., and Chen, C.S. (2000). The cyclooxygenase-2 inhibitor celecoxib induces apoptosis by blocking Akt activation in human prostate cancer cells independently of Bcl-2. J Biol Chem 275, 11397-11403.
Hull, M.A., Thomson, J.L., and Hawkey, C.J. (1999). Expression of cyclooxygenase 1 and 2 by human gastric endothelial cells. Gut 45, 529-536.
Inaba, A., Uchiyama, T., and Oka, M. (1999). Role of prostaglandin E2 in rat colon carcinoma. Hepatogastroenterology 46, 2347-2351.
Joki, T., Heese, O., Nikas, D.C., Bello, L., Zhang, J., Kraeft, S.K., Seyfried, N.T., Abe, T., Chen, L.B., Carroll, R.S., and Black, P.M. (2000). Expression of cyclooxygenase 2 (COX-2) in human glioma and in vitro inhibition by a specific COX-2 inhibitor, NS-398. Cancer Res 60, 4926-4931.
Kaplan-Machlis, B. and Klostermeyer, B.S. (1999). The cyclooxygenase-2 inhibitors: safety and effectiveness. Ann Pharmacother 33, 979-988.
Katiyar, S.K., Challa, A., McCormick, T.S., Cooper, K.D., and Mukhtar, H. (1999). Prevention of UVB-induced immunosuppression in mice by the green tea polyphenol (-)-epigallocatechin-3-gallate may be associated with alterations in IL-10 and IL-12 production. Carcinogenesis 20, 2117-2124.
Kawamori, T., Rao, C.V., Seibert, K., and Reddy, B.S. (1998). Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis. Cancer Res 58, 409-412.
Kelloff, G.J., Crowell, J.A., Steele, V.E., Lubet, R.A., Boone, C.W., Malone, W.A., Hawk, E.T., Lieberman, R., Lawrence, J.A., Kopelovich, L., Ali, I., Viner, J.L., and Sigman, C.C. (1999). Progress in cancer chemoprevention. Ann N Y Acad Sci 889, 1-13.
Kelloff, G.J., Hawk, E.T., Crowell, J.A., Boone, C.W., Nayfield, S.G., Perloff, M., Steele, V.E., and Lubet, R.A. (1996). Strategies for identification and clinical evaluation of promising chemopreventive agents. Oncology (Huntingt) 10, 1471-1484.
Kitayama, W., Denda, A., Okajima, E., Tsujiuchi, T., and Konishi, Y. (1999). Increased expression of cyclooxygenase-2 protein in rat urinary bladder tumors induced by N-butyl-N-(4-hydroxybutyl) nitrosamine. Carcinogenesis 20, 2305-2310.
Ko, Y.C., Huang, Y.L., Lee, C.H., Chen, M.J., Lin, L.M., and Tsai, C.C. (1995). Betel quid chewing, cigarette smoking and alcohol consumption related to oral cancer in Taiwan. J Oral Pathol Med 24, 450-453.
Kune, G.A. (2000). Colorectal cancer chemoprevention: aspirin, other NSAID and COX-2 inhibitors. Aust N Z J Surg 70, 452-455.
Kune, G.A., Kune, S., and Watson, L.F. (1988). Colorectal cancer risk, chronic illnesses, operations, and medications: case control results from the Melbourne Colorectal Cancer Study. Cancer Res 48, 4399-4404.
Li, M.H., Ji, C., and Cheng, S.J. (1986). Occurrence of nitroso compounds in fungi-contaminated foods: a review. Nutr Cancer 8, 63-69.
Liang, Y.C., Huang, Y.T., Tsai, S.H., Lin-Shiau, S.Y., Chen, C.F., and Lin, J.K. (1999). Suppression of inducible cyclooxygenase and inducible nitric oxide synthase by apigenin and related flavonoids in mouse macrophages. Carcinogenesis 20, 1945-1952.
Lin, J.K. and Liang, Y.C. (2000). Cancer chemoprevention by tea polyphenols. Proc Natl Sci Counc Repub China B 24, 1-13.
Loeb, W.F. and Quimby, F.W. (1989). The clinical chemistry of laboratory animals
Lu, Y.P., Lou, Y.R., Li, X.H., Xie, J.G., Brash, D., Huang, M.T., and Conney, A.H. (2000). Stimulatory effect of oral administration of green tea or caffeine on ultraviolet light-induced increases in epidermal wild-type p53, p21(WAF1/CIP1), and apoptotic sunburn cells in SKH-1 mice. Cancer Res 60, 4785-4791.
McAdam, B.F., Catella-Lawson, F., Mardini, I.A., Kapoor, S., Lawson, J.A., and FitzGerald, G.A. (1999). Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: the human pharmacology of a selective inhibitor of COX-2. Proc Natl Acad Sci U S A 96, 272-277.
Metz, N., Lobstein, A., Schneider, Y., Gosse, F., Schleiffer, R., Anton, R., and Raul, F. (2000). Suppression of azoxymethane-induced preneoplastic lesions and inhibition of cyclooxygenase-2 activity in the colonic mucosa of rats drinking a crude green tea extract. Nutr Cancer 38, 60-64.
Moore, B.C. and Simmons, D.L. (2000). COX-2 inhibition, apoptosis, and chemoprevention by nonsteroidal anti-inflammatory drugs. Curr Med Chem 7, 1131-1144.
Moore, S.R., Johnson, N.W., Pierce, A.M., and Wilson, D.F. (2000). The epidemiology of tongue cancer: a review of global incidence. Oral Dis 6, 75-84.
Morse, M.A., Kresty, L.A., Steele, V.E., Kelloff, G.J., Boone, C.W., Balentine, D.A., Harbowy, M.E., and Stoner, G.D. (1997). Effects of theaflavins on N-nitrosomethylbenzylamine-induced esophageal tumorigenesis. Nutr Cancer 29, 7-12.
Nagabhushan, M., Ng, Y.K., Elias, R., Polverini, P.J., and Solt, D.B. (1990). Acute inhibition of DNA synthesis in hamster buccal pouch epithelium exposed to indirect acting carcinogens. Cancer Lett 53, 163-173.
Oshima, M., Murai, N., Kargman, S., Arguello, M., Luk, P., Kwong, E., Taketo, M.M., and Evans, J.F. (2001). Chemoprevention of intestinal polyposis in the Apcdelta716 mouse by rofecoxib, a specific cyclooxygenase-2 inhibitor. Cancer Res 61, 1733-1740.
Pentland, A.P., Schoggins, J.W., Scott, G.A., Khan, K.N., and Han, R. (1999). Reduction of UV-induced skin tumors in hairless mice by selective COX-2 inhibition. Carcinogenesis 20, 1939-1944.
Perkins, T.M. and Shklar, G. (1982). Delay in hamster buccal pouch carcinogenesis by aspirin and indomethacin. Oral Surg Oral Med Oral Pathol 53, 170-178.
Piazza, G.A., Rahm, A.L., Krutzsch, M., Sperl, G., Paranka, N.S., Gross, P.H., Brendel, K., Burt, R.W., Alberts, D.S., and Pamukcu, R. (1995). Antineoplastic drugs sulindac sulfide and sulfone inhibit cell growth by inducing apoptosis. Cancer Res 55, 3110-3116.
Qin, G., Gopalan-Kriczky, P., Su, J., Ning, Y., and Lotlikar, P.D. (1997). Inhibition of aflatoxin B1-induced initiation of hepatocarcinogenesis in the rat by green tea. Cancer Lett 112, 149-154.
Rao, C.V., Rivenson, A., Simi, B., Zang, E., Kelloff, G., Steele, V., and Reddy, B.S. (1995). Chemoprevention of colon carcinogenesis by sulindac, a nonsteroidal anti-inflammatory agent. Cancer Res 55, 1464-1472.
Reddy, B.S., Kawamori, T., Lubet, R., Steele, V., Kelloff, G., and Rao, C.V. (1999). Chemopreventive effect of S-methylmethane thiosulfonate and sulindac administered together during the promotion/progression stages of colon carcinogenesis. Carcinogenesis 20, 1645-1648.
Reddy, B.S., Rao, C.V., and Seibert, K. (1996). Evaluation of cyclooxygenase-2 inhibitor for potential chemopreventive properties in colon carcinogenesis. Cancer Res 56, 4566-4569.
Reynolds, N.J., McCombie, S.W., Shankar, B.B., Bishop, W.R., and Fisher, G.J. (1997). SCH 47112, a novel staurosporine derivative, inhibits 12-O-tetradecanoylphorbol-13-acetate-induced inflammation and epidermal hyperplasia in hairless mouse skin. Arch Dermatol Res 289, 540-546.
Rice, P.L., Goldberg, R.J., Ray, E.C., Driggers, L.J., and Ahnen, D.J. (2001). Inhibition of extracellular signal-regulated kinase 1/2 phosphorylation and induction of apoptosis by sulindac metabolites. Cancer Res 61, 1541-1547.
Rioux, N. and Castonguay, A. (1998). Prevention of NNK-induced lung tumorigenesis in A/J mice by acetylsalicylic acid and NS-398. Cancer Res 58, 5354-5360.
Salley, J.J. (1954). Experimental carcinogenesis in the cheek pouch of the syrian hamster. Dental Res 33, 253-262.
Samaha, H.S., Kelloff, G.J., Steele, V., Rao, C.V., and Reddy, B.S. (1997). Modulation of apoptosis by sulindac, curcumin, phenylethyl-3-methylcaffeate, and 6-phenylhexyl isothiocyanate: apoptotic index as a biomarker in colon cancer chemoprevention and promotion. Cancer Res 57, 1301-1305.
Sato, D. (1999). Inhibition of urinary bladder tumors induced by N-butyl-N-(4-hydroxybutyl)-nitrosamine in rats by green tea. Int J Urol 6, 93-99.
Sawaoka, H., Kawano, S., Tsuji, S., Tsujii, M., Gunawan, E.S., Takei, Y., Nagano, K., and Hori, M. (1998). Cyclooxygenase-2 inhibitors suppress the growth of gastric cancer xenografts via induction of apoptosis in nude mice. Am J Physiol 274, G1061-G1067
Sawaoka, H., Tsuji, S., Tsujii, M., Gunawan, E.S., Sasaki, Y., Kawano, S., and Hori, M. (1999). Cyclooxygenase inhibitors suppress angiogenesis and reduce tumor growth in vivo. Lab Invest 79, 1469-1477.
Scioscia, K.A., Snyderman, C.H., D'Amico, F., Comsa, S., Rueger, R., and Light, B. (2000). Effects of arachidonic acid metabolites in a murine model of squamous cell carcinoma. Head Neck 22, 149-155.
Sheng, H., Shao, J., Kirkland, S.C., Isakson, P., Coffey, R.J., Morrow, J., Beauchamp, R.D., and DuBois, R.N. (1997). Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2. J Clin Invest 99, 2254-2259.
Sheng, H., Williams, C.S., Shao, J., Liang, P., DuBois, R.N., and Beauchamp, R.D. (1998). Induction of cyclooxygenase-2 by activated Ha-ras oncogene in Rat-1 fibroblasts and the role of mitogen-activated protein kinase pathway. J Biol Chem 273, 22120-22127.
Shiff, S.J., Qiao, L., Tsai, L.L., and Rigas, B. (1995). Sulindac sulfide, an aspirin-like compound, inhibits proliferation, causes cell cycle quiescence, and induces apoptosis in HT-29 colon adenocarcinoma cells. J Clin Invest 96, 491-503.
Shiotani, H., Denda, A., Yamamoto, K., Kitayama, W., Endoh, T., Sasaki, Y., Tsutsumi, N., Sugimura, M., and Konishi, Y. (2001). Increased expression of cyclooxygenase-2 protein in 4-nitroquinoline-1-oxide-induced rat tongue carcinomas and chemopreventive efficacy of a specific inhibitor, nimesulide. Cancer Res 61, 1451-1456.
Smalley, W., Ray, W.A., Daugherty, J., and Griffin, M.R. (1999). Use of nonsteroidal anti-inflammatory drugs and incidence of colorectal cancer: a population-based study. Arch Intern Med 159, 161-166.
Solt, D.B., Calderon-Solt, L., and Odajima, T. (1985). Rapid induction of carcinomas and gamma-glutamyl transpeptidase-rich clones in N-methyl-N-benzylnitrosamine-treated hamster buccal pouch. J Natl Cancer Inst 74, 437-445.
Spanos, G.A. (1990). Influence of processing and storage on the phenolic composition of apple juice. J.Agric.food Chem. 38, 1572
Steinbach, G., Lynch, P.M., Phillips, R.K., Wallace, M.H., Hawk, E., Gordon, G.B., Wakabayashi, N., Saunders, B., Shen, Y., Fujimura, T., Su, L.K., and Levin, B. (2000). The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N Engl J Med 342, 1946-1952.
Suganuma, M., Okabe, S., Sueoka, N., Sueoka, E., Matsuyama, S., Imai, K., Nakachi, K., and Fujiki, H. (1999). Green tea and cancer chemoprevention. Mutat Res 428, 339-344.
Sumitani, K., Kamijo, R., Toyoshima, T., Nakanishi, Y., Takizawa, K., Hatori, M., and Nagumo, M. (2001). Specific inhibition of cyclooxygenase-2 results in inhibition of proliferation of oral cancer cell lines via suppression of prostaglandin E2 production. J Oral Pathol Med 30, 41-47.
Tanaka, T., Nishikawa, A., Mori, Y., Morishita, Y., and Mori, H. (1989). Inhibitory effects of non-steroidal anti-inflammatory drugs, piroxicam and indomethacin on 4-nitroquinoline 1-oxide-induced tongue carcinogenesis in male ACI/N rats. Cancer Lett 48, 177-182.
Tardieu, D., Jaeg, J.P., Deloly, A., Corpet, D.E., Cadet, J., and Petit, C.R. (2000). The COX-2 inhibitor nimesulide suppresses superoxide and 8-hydroxy-deoxyguanosine formation, and stimulates apoptosis in mucosa during early colonic inflammation in rats. Carcinogenesis 21, 973-976.
Taylor, M.T., Lawson, K.R., Ignatenko, N.A., Marek, S.E., Stringer, D.E., Skovan, B.A., and Gerner, E.W. (2000). Sulindac sulfone inhibits K-ras-dependent cyclooxygenase-2 expression in human colon cancer cells. Cancer Res 60, 6607-6610.
Thompson, H.J., Jiang, C., Lu, J., Mehta, R.G., Piazza, G.A., Paranka, N.S., Pamukcu, R., and Ahnen, D.J. (1997). Sulfone metabolite of sulindac inhibits mammary carcinogenesis. Cancer Res 57, 267-271.
Thompson, W.J., Piazza, G.A., Li, H., Liu, L., Fetter, J., Zhu, B., Sperl, G., Ahnen, D., and Pamukcu, R. (2000). Exisulind induction of apoptosis involves guanosine 3',5'-cyclic monophosphate phosphodiesterase inhibition, protein kinase G activation, and attenuated beta-catenin. Cancer Res 60, 3338-3342.
Tomozawa, S., Nagawa, H., Tsuno, N., Hatano, K., Osada, T., Kitayama, J., Sunami, E., Nita, M.E., Ishihara, S., Yano, H., Tsuruo, T., Shibata, Y., and Muto, T. (1999). Inhibition of haematogenous metastasis of colon cancer in mice by a selective COX-2 inhibitor, JTE-522. Br J Cancer 81, 1274-1279.
van Lieshout, E.M., Tiemessen, D.M., Peters, W.H., and Jansen, J.B. (1997). Effects of nonsteroidal anti-inflammatory drugs on glutathione S-transferases of the rat digestive tract. Carcinogenesis 18, 485-490.
Weyant, M.J., Carothers, A.M., Dannenberg, A.J., and Bertagnolli, M.M. (2001). (+)-Catechin inhibits intestinal tumor formation and suppresses focal adhesion kinase activation in the min/+ mouse. Cancer Res 61, 118-125.
Williams, C.S., Mann, M., and DuBois, R.N. (1999). The role of cyclooxygenases in inflammation, cancer, and development. Oncogene 18, 7908-7916.
Wilson, J.W. and Potten, C.S. (2000). The effect of exogenous prostaglandin administration on tumor size and yield in Min/+ mice. Cancer Res 60, 4645-4653.
Wolff, H., Saukkonen, K., Anttila, S., Karjalainen, A., Vainio, H., and Ristimaki, A. (1998). Expression of cyclooxygenase-2 in human lung carcinoma. Cancer Res 58, 4997-5001.
Wu-Wang, C.Y., Wang, S.L., Brigham, M., Correa, A., Slomiany, A., and Slomiany, B.L. (1993). Expression of prostaglandin E2 receptor in hamster buccal pouch: effect of benzo (a) pyrene and nicotine. Prostaglandins Leukot Essent Fatty Acids 49, 821-826.
Yang, C.S. (1980). Research on esophageal cancer in China: a review. Cancer Res 40, 2633-2644.
郭彥彬. "嚼檳榔與口腔癌基因、抑癌基因的突變和表現"，國家衛生研究院，(2000):1-3.
楊奕馨. "檳榔嚼塊與口腔癌流行病學研究"，國家衛生研究院，(2000):15-23.
|